Entellus Medical (ENTL) Misses Q4 EPS by 1c

Entellus Medical (NASDAQ: ENTL) reported Q4 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $18.1 million versus the consensus estimate of $17.52 million.

GUIDANCE:

Entellus Medical sees FY2016 revenue of $73-77 million, versus the consensus of $74 million.

For earnings history and earnings-related data on Entellus Medical (ENTL) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• XP Inc eyes US banking license as next business step
• Is Treasury selloff a major issue for stock market bulls?